How Pfizer’s Allergan Purchase Will Boost Its Drug Pipeline

With several of its blockbuster drugs coming off patent, Pfizer’s acquisition of Allergan would strengthen its pipeline with drugs aimed at specialty markets such as cosmetics and dermatology.